Oligosaccharides as Potential Regulators of Gut Microbiota and Intestinal Health in Post-COVID-19 Management
Pharmaceuticals · 09.06.2023 · 16 (6) · 860
DOI: 10.3390/ph16060860 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 09.06.2023. Verfasst von Kit-Leong Cheong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Product…. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key-Area Research and Development Program of Guangdong Province, The Innovative Team Program of High Education of Guangdong Province, The Program for Scientific Research Start-up Funds of Guangdong Ocean University.
Abstract (Originalsprache)
The COVID-19 pandemic has had a profound impact worldwide, resulting in long-term health effects for many individuals. Recently, as more and more people recover from COVID-19, there is an increasing need to identify effective management strategies for post-COVID-19 syndrome, which may include diarrhea, fatigue, and chronic inflammation. Oligosaccharides derived from natural resources have been shown to have prebiotic effects, and emerging evidence suggests that they may also have immunomodulatory and anti-inflammatory effects, which could be particularly relevant in mitigating the long-term effects of COVID-19. In this review, we explore the potential of oligosaccharides as regulators of gut microbiota and intestinal health in post-COVID-19 management. We discuss the complex interactions between the gut microbiota, their functional metabolites, such as short-chain fatty acids, and the immune system, highlighting the potential of oligosaccharides to improve gut health and manage post-COVID-19 syndrome. Furthermore, we review evidence of gut microbiota with angiotensin-converting enzyme 2 expression for alleviating post-COVID-19 syndrome. Therefore, oligosaccharides offer a safe, natural, and effective approach to potentially improving gut microbiota, intestinal health, and overall health outcomes in post-COVID-19 management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Guangdong Provincial Engineering Technology Research Center of Seaf…
- Department of Biology, College of Science, Shantou University, Shantou 515063, China.
- Guangxi Key Laboratory of Beibu Gulf Biodiversity Conservation, Beibu Gulf University, Qinzhou 535000, China.
ORCID-Profile: Kit-Leong Cheong, Shutong Chen, Bo Teng, Suresh Veeraperumal, Karsoon Tan
Förderung
- Key-Area Research and Development Program of Guangdong Province
- The Innovative Team Program of High Education of Guangdong Province
- The Program for Scientific Research Start-up Funds of Guangdong Ocean University
Zitieren
APA
Cheong, K. L., Chen, S., Teng, B., Veeraperumal, S., Zhong, S., & Tan, K. (2023). Oligosaccharides as Potential Regulators of Gut Microbiota and Intestinal Health in Post-COVID-19 Management. Pharmaceuticals, 16(6), 860. https://doi.org/10.3390/ph16060860
Vancouver
Cheong KL, Chen S, Teng B, Veeraperumal S, Zhong S, Tan K. Oligosaccharides as Potential Regulators of Gut Microbiota and Intestinal Health in Post-COVID-19 Management. Pharmaceuticals. 2023;16(6):860. doi:10.3390/ph16060860
BibTeX
@article{Cheong2023,
author = {Cheong, Kit-Leong and Chen, Shutong and Teng, Bo and Veeraperumal, Suresh and Zhong, Saiyi and Tan, Karsoon},
title = {Oligosaccharides as Potential Regulators of Gut Microbiota and Intestinal Health in Post-COVID-19 Management},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {6},
pages = {860},
doi = {10.3390/ph16060860}
}
EUVIMED